Home Suppliers hVIVO

hVIVO

Message Recommend
Claim Listing Report Page Visit Website

hVIVO

Overview Activity & Updates Locations Contacts

About

Clinical Research
Product Development

hVIVO

Global Leader in Infectious Disease Vaccine Testing and Human Challenge Trials

As a trailblazer in the field of challenge trials and laboratory services, this company has established itself as the global leader in testing infectious and respiratory disease vaccines and therapeutics. The company specializes in human challenge clinical trials and boasts a repertoire of reliable and rigorously validated models for various diseases, including seasonal influenza, RSV, COVID-19, human rhinovirus, and malaria. Their state-of-the-art facilities, strategically located in Whitechapel, London and soon expanding to Canary Wharf, enable them to meet growing demands and provide cutting-edge clinical trial experiences. These facilities house advanced laboratories and quarantine units designed to ensure optimal conditions for both volunteers and researchers.

The company's extensive history, rooted in the pioneering human challenge studies of the UK's Common Cold Unit, underscores their unparalleled expertise and long-standing commitment to improving global health. Their portfolio, which includes over 11 challenge study models, allows them to offer tailored services for pharmaceutical and biotech companies. Through their specialised hLAB unit, they provide sophisticated virology and immunology laboratory services, enhancing the discovery and development of antiviral compounds. The company’s innovative approach, combined with their recruitment arm FluCamp, ensures access to healthy volunteers, furthering the understanding and treatment of respiratory and viral illnesses.

Global Leader in Infectious Disease Vaccine Testing and Human Challenge Trials

As a trailblazer in the field of challenge trials and laboratory services, this company has established itself as the global leader in testing infectious and respiratory disease vaccines and therapeutics. The company specializes in human challenge clinical trials and boasts a repertoire of reliable and rigorously validated models for various diseases, including seasonal influenza, RSV, COVID-19, human rhinovirus, and malaria. Their state-of-the-art facilities, strategically located in Whitechapel, London and soon expanding to Canary Wharf, enable them to meet growing demands and provide cutting-edge clinical trial experiences. These facilities house advanced laboratories and quarantine units designed to ensure optimal conditions for both volunteers and researchers.

The company's extensive history, rooted in the pioneering human challenge studies of the UK's Common Cold Unit, underscores their unparalleled expertise and long-standing commitment to improving global health. Their portfolio, which includes over 11 challenge study models, allows them to offer tailored services for pharmaceutical and biotech companies. Through their specialised hLAB unit, they provide sophisticated virology and immunology laboratory services, enhancing the discovery and development of antiviral compounds. The company’s innovative approach, combined with their recruitment arm FluCamp, ensures access to healthy volunteers, furthering the understanding and treatment of respiratory and viral illnesses.

Show More

Contacts

No Contact Logo
Yamin Khan